Gene · 5268
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer. | Clin Transl Med | 2024 | 39113221 | PubTator, text mining | PubMed |
| miR-1204 Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting MASPIN. | Protein Pept Lett | 2024 | 39082173 | PubTator, text mining | PubMed |
| Prognostic value of Maspin protein level in patients with triple negative breast cancer. | Sci Rep | 2024 | 38987610 | PubTator, text mining | PubMed |
| Evaluation of the diagnostic utility of NCOA3, Maspin and VHL protein expression in pancreatic ductal adenocarcinoma: An immunohistochemical study. | Ann Diagn Pathol | 2024 | 38901088 | PubTator, text mining | PubMed |
| Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer-A Validation Study. | Int J Mol Sci | 2024 | 38612418 | PubTator, text mining | PubMed |
| Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters. | Cancers (Basel) | 2024 | 38611078 | PubTator, text mining | PubMed |
| Exploring Genetic Determinants: A Comprehensive Analysis of Serpin B Family SNPs and Prognosis in Glioblastoma Multiforme Patients. | Cancers (Basel) | 2024 | 38539447 | PubTator, text mining | PubMed |
| Split Gp41-1 intein splicing as a model to evaluate the cellular location of the oncosuppressor Maspin in an in vitro model of osteosarcoma. | Cell Biochem Funct | 2024 | 38509770 | PubTator, text mining | PubMed |
| Exploring diverse programmed cell-death patterns to develop a novel gene signature for predicting the prognosis of lung adenocarcinoma patients. | J Thorac Dis | 2024 | 38505063 | PubTator, text mining | PubMed |
| DPM1 modulates desmosomal adhesion and epidermal differentiation through SERPINB5. | J Cell Biol | 2024 | 38477878 | PubTator, text mining | PubMed |
| A meta‑ and bioinformatics analysis of maspin expression levels influencing the prognosis of patients with breast cancer. | Oncol Lett | 2024 | 38464336 | PubTator, text mining | PubMed |
| SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway. | Int Immunopharmacol | 2024 | 38460302 | PubTator, text mining | PubMed |
| [Prediction of prognosis of patients with radical resection of intrahepatic cholangiocarcinoma based on single cell omics]. | Zhonghua Wai Ke Za Zhi | 2024 | 38432673 | PubTator, text mining | PubMed |
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System. | Int J Mol Sci | 2024 | 38279253 | PubTator, text mining | PubMed |
| Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets. | Cell Commun Signal | 2024 | 38279122 | PubTator, text mining | PubMed |
| Reshaping the Landscape of the Genome: Toolkits for Precise DNA Methylation Manipulation and Beyond. | JACS Au | 2024 | 38274248 | PubTator, text mining | PubMed |
| The Role of Galectin3, Tubulinβ, and Maspin in Promoting Tumor Budding in Colorectal Carcinoma and Their Clinical Implications. | Appl Immunohistochem Mol Morphol | 2024 | 38251657 | PubTator, text mining | PubMed |
| Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc. | J Oncol | 2024 | 38249992 | PubTator, text mining | PubMed |
| Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma. | Biochem Genet | 2024 | 38245886 | PubTator, text mining | PubMed |
| PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2024 | 38226611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5268/papers?page=4